AAAAAA
Results: 1-25/570
Authors:
AGAM G
LEVINE J
Citation: G. Agam et J. Levine, GLYCOGEN-SYNTHASE KINASE-3 - A NEW TARGET FOR LITHIUMS EFFECTS IN BIPOLAR PATIENTS, Human psychopharmacology, 13(7), 1998, pp. 463-465
Authors:
SHARP HM
HEALY D
FEAR CF
Citation: Hm. Sharp et al., SYMPTOMS OR SIDE-EFFECTS - METHODOLOGICAL HAZARDS AND THERAPEUTIC PRINCIPLES, Human psychopharmacology, 13(7), 1998, pp. 467-475
Authors:
WATERS AJ
Citation: Aj. Waters, THE EFFECTS OF SMOKING ON PERFORMANCE ON THE GARNER SPEEDED CLASSIFICATION TASK, Human psychopharmacology, 13(7), 1998, pp. 477-491
Authors:
PERAULT MC
BERGOUGNAN L
PAILLAT A
ZIELENIUK I
ROSENZWEIG P
VANDEL B
Citation: Mc. Perault et al., LACK OF INTERACTION BETWEEN AMISULPRIDE AND LORAZEPAM ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-VOLUNTEERS, Human psychopharmacology, 13(7), 1998, pp. 493-500
Authors:
STIVALET P
ESQUIVIE D
BARRAUD PA
LEIFFLEN D
RAPHEL C
Citation: P. Stivalet et al., EFFECTS OF MODAFINIL ON ATTENTIONAL PROCESSES DURING 60 HOURS OF SLEEP-DEPRIVATION, Human psychopharmacology, 13(7), 1998, pp. 501-507
Authors:
DAHL AA
LOWERT A
ASSERSON S
BJARKING L
BERGLUND J
KRISTENSEN F
NORUM D
TONSETH S
BAYER L
MAEHLUM E
Citation: Aa. Dahl et al., HYDROXYLATION POLYMORPHISM OF DEBRISOQUINE HYDROXYLASE (CYP2D6) IN PATIENTS WITH SCHIZOPHRENIA IN NORWAY AND DENMARK, Human psychopharmacology, 13(7), 1998, pp. 509-511
Authors:
CARTER SJ
CASSADAY HJ
Citation: Sj. Carter et Hj. Cassaday, STATE-DEPENDENT RETRIEVAL AND CHLORPHENIRAMINE, Human psychopharmacology, 13(7), 1998, pp. 513-523
Authors:
GILLMAN PK
HODGENS S
Citation: Pk. Gillman et S. Hodgens, SEROTONIN SYNDROME FOLLOWING SSRI MONO-THERAPY, Human psychopharmacology, 13(7), 1998, pp. 525-526
Authors:
MASUDA Y
TAKEMURA T
SUGIYAMA T
Citation: Y. Masuda et al., HYPERTRIGLYCERIDEMIA ASSOCIATED WITH THE TREATMENT OF AMITRIPTYLINE AND MAPROTILINE, Human psychopharmacology, 13(7), 1998, pp. 527-528
Citation: CURRENT-AWARENESS IN HUMAN PSYCHOPHARMACOLOGY, Human psychopharmacology, 13(7), 1998, pp. 533-538
Authors:
HINDMARCH I
Citation: I. Hindmarch, ITS ALL IN THE MIND - MEASURING SOMNOLENCE AND CNS DRUG SIDE-EFFECTS, Human psychopharmacology, 13(6), 1998, pp. 385-387
Authors:
TAYA K
WATANABE Y
Citation: K. Taya et Y. Watanabe, NEURO-REGULATIONAL THERAPY FOR NEUROPSYCHIATRIC DISEASES USING CA++ ANTAGONISTS, Human psychopharmacology, 13(6), 1998, pp. 389-405
Authors:
DEHPOUR AR
MEYSAMI F
EBRAHIMIDARYANI N
AKBARLOO N
Citation: Ar. Dehpour et al., INHIBITION BY LITHIUM OF OPIOID WITHDRAWAL-LIKE SYNDROME AND PHYSICALDEPENDENCY IN A MODEL OF ACUTE CHOLESTASIS IN MICE, Human psychopharmacology, 13(6), 1998, pp. 407-412
Authors:
MACKAY FJ
WILTON LV
PEARCE GL
FREEMANTLE SN
MANN RD
Citation: Fj. Mackay et al., THE SAFETY OF RISPERIDONE - A POSTMARKETING STUDY ON 7684 PATIENTS, Human psychopharmacology, 13(6), 1998, pp. 413-418
Authors:
CHAUDHRY HR
NAJAM N
NAQVI A
Citation: Hr. Chaudhry et al., THE VALUE OF AMINEPTINE IN DEPRESSED-PATIENTS TREATED WITH COGNITIVE-BEHAVIORAL PSYCHOTHERAPY, Human psychopharmacology, 13(6), 1998, pp. 419-424
Authors:
HERRMANN WM
FUDER H
Citation: Wm. Herrmann et H. Fuder, REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR, IS NONSEDATIVE AND DOES NOT IMPAIR PSYCHOMOTOR PERFORMANCE IN HEALTHY-SUBJECTS, Human psychopharmacology, 13(6), 1998, pp. 425-433
Authors:
WYNCHANK D
BERK M
Citation: D. Wynchank et M. Berk, BEHAVIORAL-CHANGES IN DOGS WITH ACRAL LICK DERMATITIS DURING A 2-MONTH EXTENSION PHASE OF FLUOXETINE TREATMENT, Human psychopharmacology, 13(6), 1998, pp. 435-437
Authors:
OBONSAWIN MC
ROBERTSON A
CRAWFORD JR
PERERA C
WALKER S
BLACKMORE L
PARKER DM
BESSON JAO
BESSON JAO
Citation: Mc. Obonsawin et al., NON-MNESTIC COGNITIVE FUNCTION IN THE SCOPOLAMINE MODEL OF ALZHEIMERS-DISEASE, Human psychopharmacology, 13(6), 1998, pp. 439-449
Authors:
TERAO T
Citation: T. Terao, EFFECT OF CARBAMAZEPINE AND CLONAZEPAM COMBINATION ON CHARLES-BONNET-SYNDROME - A CASE-REPORT, Human psychopharmacology, 13(6), 1998, pp. 451-453
Authors:
OKADA F
OKAJIMA K
TOKUMITSU Y
Citation: F. Okada et al., CONTRADIRECT EFFECTS ON NEURONAL-ACTIVITY IN TREATING DEPRESSION, Human psychopharmacology, 13(6), 1998, pp. 455-456
Authors:
GEORGE MS
Citation: Ms. George, WHY WOULD YOU EVER WANT TO - TOWARD UNDERSTANDING THE ANTIDEPRESSANT EFFECT OF PREFRONTAL RTMS, Human psychopharmacology, 13(5), 1998, pp. 307-313
Authors:
PITA G
Citation: G. Pita, DISTURBANCES IN RECENT MEMORY AND BEHAVIORAL-CHANGES CAUSED BY THE TREATMENT WITH INTRAVENTRICULAR MORPHINE ADMINISTRATION (IVM) IN SEVERE CANCER PAIN, Human psychopharmacology, 13(5), 1998, pp. 315-323
Authors:
MIYAHARA S
KOMORI T
SHIZUYA K
NOMURA J
Citation: S. Miyahara et al., CHANGES OF SERUM ADENOSINE-DEAMINASE ACTIVITY-INDUCED BY STRESS IN RATS, Human psychopharmacology, 13(5), 1998, pp. 325-327
CLINICAL IMPLICATIONS OF DOSE-DEPENDENT CYTOCHROME-P-450 DRUG-DRUG INTERACTIONS WITH ANTIDEPRESSANTS
Authors:
DEVANE CL
Citation: Cl. Devane, CLINICAL IMPLICATIONS OF DOSE-DEPENDENT CYTOCHROME-P-450 DRUG-DRUG INTERACTIONS WITH ANTIDEPRESSANTS, Human psychopharmacology, 13(5), 1998, pp. 329-336
Authors:
CURRAN S
WATTIS JP
Citation: S. Curran et Jp. Wattis, CRITICAL FLICKER FUSION THRESHOLD - A USEFUL RESEARCH TOOL IN PATIENTS WITH ALZHEIMERS-DISEASE, Human psychopharmacology, 13(5), 1998, pp. 337-355